reports
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Michiel Declercq
- Thibault Leneeuw
- Wim Hoste
- Wim Lewi
- Jacob Mekhael
Onward Medical Launches capital increase for gross proceeds of € 50m
Onward announced the launch of a capital increase by way of a bookbuild offering through a private placement with institutional investors intending to raise gross proceeds of approx. € 50m. The capital raise is expected to be anchored by multiple long-only institutions, including existing and new shareholders. Onward expects to use the net proceeds towards development of the implantable ARC-IM system (40%) and to support commercialisation of the external ARC-EX device in upper limb function in S...
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR ...
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Private placement is expected to be anchored by multiple long-only institutions, in...
- ING Helpdesk
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
Bekaert - Update on the Share Buyback Program and Liquidity Agreement Update on the Share Buyback Program and the Liquidity Agreement Period from 9 October 2025 to 15 October 2025 Share Buyback ProgramOn , Bekaert announced the start of the next tranche of its share buyback program, for a total maximum consideration of up to € 25 million. As announced previously, the purpose of the Program is to cancel all shares repurchased. Bekaert announces today that during the period from 9 October 2025 to 15 October 2025, Kepler Cheuvreux SA on behalf of Bekaert has bought 52 655 shares. The tabl...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquid...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquiditeitsovereenkomst Update over het Inkoopprogramma van Eigen Aandelen en de Liquiditeitsovereenkomst Periode van 9 oktober 2025 tot 15 oktober 2025 Inkoopprogramma van Eigen AandelenOp , kondigde Bekaert de start aan van de volgende tranche van haar inkoopprogramma, voor een totaalbedrag van maximaal € 25 miljoen. Zoals eerder aangekondigd heeft het inkoopprogramma tot doel alle ingekochte aandelen te vernietigen. Bekaert kondigt vandaag aan dat gedurende de periode van 9 oktober 2025 tot 15 oktober 2025, Kepler C...
- ING Helpdesk
Benelux Morning Notes
ABN AMRO: Pre-close 3Q: HAL inclusion. Ahold Delhaize: Peer Albertsons 2Q25/26 results. AMG: Lithium supply deal with Beijing Easpring. ASML: 3Q25 results supportive. Barco: 3Q25 trading update inline, surprise buyback. Belgian telcos: Start of the market test for cooperation agreement in Flanders. CM.com: Preview 3Q25 trading update. NSI: Vacancy increase as expected, marginal guidance update. Staffing sector: PageGroup 3Q25 trading update. Zabka: 3Q25 Preview - Like-for-Like(...
- Guy Sips
- Jacob Mekhael
- Mathijs Geerts Danau
- Michiel Declercq
- Thibault Leneeuw
- Wim Hoste
EVS Broadcast Equipment SA: 1 director
A director at EVS Broadcast Equipment SA sold 2,750 shares at 35.920EUR and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
- Emmanuel Matot
- Emmanuel Matot
- ING Helpdesk
- Martijn Den Drijver
Bekaert : Failed strategy and competitive pressure set to hit hard
We downgrade our recommendation on Bekaert to Underperform from Neutral with an updated price target of €34.5 per share. Roughly two years after the December 2023 Capital Markets Day, we conclude that very little has come of the outlined strategy (high growth and high EBIT margins from the Growth Platforms) and that is not likely to change in the remainder of 2025 or 2026, while most of the other targets (step up M&A, ROCE) are also out of sight. We lower our estimates for 2025-2027 materially, ...
- Jacob Mekhael
Onward Medical Preliminary 3Q25 update shows ARC-EX US commercialisati...
Onward reported a preliminary 3Q25 update, which shows that ARC-EX commercialisation in the US remains on track. With 40 ARC-EX systems sold in the US in 3Q25 (20 systems in 2Q25), we believe FY25 consensus of 150 devices is within reach if this rate of uptake continues for the remainder of the year. Looking ahead, the company previously guided it anticipates home use label expansion for ARC-EX in the US, and plans to initiate the pivotal Empower BP trial of the implantable ARC-IM system in SCI ...
- Hilde Van Boxstael
- Jacob Mekhael
- Mathijs Geerts Danau
- Thomas Couvreur
- Wim Lewi
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accele...
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States EINDHOVEN, the Netherlands, Oct. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announces the following key achievements in the third quarter of 2025: Commercial traction: 40 ARC-EX® Systems were sold in Q3, demonstrating continued strong commercial traction...
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
Bekaert - Update on the Share Buyback Program and Liquidity Agreement Update on the Share Buyback Program and the Liquidity Agreement Period from 2 October 2025 to 8 October 2025 Share Buyback ProgramOn , Bekaert announced the start of the next tranche of its share buyback program, for a total maximum consideration of up to € 25 million. As announced previously, the purpose of the Program is to cancel all shares repurchased. Bekaert announces today that during the period from 2 October 2025 to 8 October 2025, Kepler Cheuvreux SA on behalf of Bekaert has bought 41 500 shares. The table ...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquid...
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquiditeitsovereenkomst Update over het Inkoopprogramma van Eigen Aandelen en de Liquiditeitsovereenkomst Periode van 2 oktober 2025 tot 8 oktober 2025 Inkoopprogramma van Eigen AandelenOp , kondigde Bekaert de start aan van de volgende tranche van haar inkoopprogramma, voor een totaalbedrag van maximaal € 25 miljoen. Zoals eerder aangekondigd heeft het inkoopprogramma tot doel alle ingekochte aandelen te vernietigen. Bekaert kondigt vandaag aan dat gedurende de periode van 2 oktober 2025 tot 8 oktober 2025, Kepler Cheuvre...
Bekaert: Publication transparency notification
Bekaert: Publication transparency notification Publication of a transparency notification(in accordance with the Law of 2 May 2007 on disclosure of major holdings) NV Bekaert SA (“Bekaert”) has received a transparency notification dated 6 October 2025 indicating that Norges Bank has crossed the threshold of 3%, as a result of the acquisition or disposal of voting securities or voting rights in Bekaert. The notification dated 6 October 2025 contains the following information: Reason for the notification: acquisition or disposal of voting securities or voting rightsdownward crossing of ...
Bekaert: Openbaarmaking over transparantiekennisgeving
Bekaert: Openbaarmaking over transparantiekennisgeving Openbaarmaking over transparantiekennisgeving(conform de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen) NV Bekaert SA (“Bekaert”) heeft een op 6 oktober 2025 gedateerde transparantiekennisgeving ontvangen waaruit blijkt dat Norges Bank de deelnemingsdrempel van 3% heeft overschreden, als gevolg van de verwerving of overdracht van stemrechtverlenende effecten of stemrechten in Bekaert. De op 6 oktober 2025 gedateerde kennisgeving bevat de volgende informatie: Reden voor de kennisgeving: een verwerving of overdr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.